Two Doses Of Oxford/AstraZeneca Vaccine Prompts Good Immune Response: Early Data Reveals
Data published earlier from later Phase 3 trials showed efficacy was 62 per cent for trial participants given two full doses
from NDTV Profit - Latest https://ift.tt/3oWDibU
Data published earlier from later Phase 3 trials showed efficacy was 62 per cent for trial participants given two full doses
from NDTV Profit - Latest https://ift.tt/3oWDibU
Data published earlier from later Phase 3 trials showed efficacy was 62 per cent for trial participants given two full doses
Comments
Post a Comment